Prevalence and characteristics of type 2 diabetes mellitus in 9-18 year-old children with diabetic ketoacidosis

Journal of Pediatric Endocrinology and Metabolism

Volumn 18, Issue 9, 2005, Pages 865-872

  Sapru, Anil ^a,b,c   Gitelman, Stephen E ^a   Bhatia, Suruchi ^b   Dubin, Ruth F ^a   Newman, Thomas B ^a,c   Flori, Heidi ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adolescent; Diabetic ketoacidosis; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; AUTOANTIBODY; BICARBONATE; C PEPTIDE; GLUCOSE; INSULIN; METFORMIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DRUG RESPONSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INFORMATION PROCESSING; INSULIN INFUSION; JUVENILE DIABETES MELLITUS; KETOACIDOSIS; MAJOR CLINICAL STUDY; MALE; PH; PREVALENCE; PROTEIN BLOOD LEVEL; REHYDRATION; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 27844525387     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2005.18.9.865     Document Type: Article

References (33)

1. Cohn BA, Cirillo PM, Wingard DL, Austin DF, Roffers SD. Gender differences in hospitalizations for IDDM among adolescents in California, 1991. Implications for prevention. Diabetes Care 1997; 20: 1677-1682.
2. Glaser N, Barnett P, McCaslin I, Nelson D, Trainor J, Louie J, Kaufman F, Quayle K, Roback M, Malley R, Kuppermann N; Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med 2001; 344: 264-269.
3. Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IR, Rowley MJ, Zimmet PZ, Lebovitz HE. GAD antibody negative NIDDM in adult Black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes 1994; 43: 741-745.
4. Pinero-Pilona A, Litonjua P, Aviles-Santa L, Raskin P. Idiopathic type 1 diabetes in Dallas, Texas: a 5-year experience. Diabetes Care 2001; 24: 1014-1018.
5. Sobngwi E, Gautier JF. Adult-onset idiopathic type I or ketosis-prone type II diabetes: evidence to revisit diabetes classification. Diabetologia 2002; 45: 283-285.
6. Aizawa T, Funase Y, Katakura. M, Asanuma N, Yamauchi K, Yoshizawa K, Hashizume K. Ketosis-onset diabetes in young adults with subsequent noninsulin-dependency, a link between IDDM and NIDDM? Diabet Med 1997; 14: 989-991.
7. Morrison EY, Richards R. Clinical profile of diabetes mellitus in Jamaica (phasic insulin dependence). West Indian Med J 1985; 34: 94-97.
8. Pitteloud N, Philippe J. Characteristics of Caucasian type 2 diabetic patients during ketoacidosis and at follow-up. Schweiz Med Wochenschr 2000; 130: 576-582.
9. Rheeder P, Stolk RP, Grobbee DE. Ethnic differences in C-peptide levels and anti-GAD antibodies in South African patients with diabetic ketoacidosis. Q J Med 2001; 94: 39-43.
10. Tan KC, Mackay IR, Zimmet PZ, Hawkins BR, Lam KS. Metabolic and immunologic features of Chinese patients with atypical diabetes mellitus. Diabetes Care 2000; 23: 335-338.
11. Tanaka K, Moriya T, Kanamori A, Yajima Y. Analysis and a long-term follow up of ketosis-onset Japanese NIDDM patients. Diabetes Res Clin Pract 1999; 44: 137-146.
12. Pinhas-Hamiel O, Dolan LM, Zeitler PS. Diabetic ketoacidosis among obese African-American adolescents with NIDDM. Diabetes Care 1997; 20: 484-486.
13. Sellers EA, Dean HJ. Diabetic ketoacidosis: a complication of type 2 diabetes in Canadian aboriginal youth. Diabetes Care 2000; 23: 1202-1204.
14. Scott CR, Smith JM, Cradock MM, Pihoker C. Characteristics of youth-onset noninsulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis. Pediatrics 1997; 100: 84-91.
15. Maldonado M, Hampe CS, Gaur LK, D'Amico S, Iyer D, Hammerle LP, Bolgiano D, Rodriguez L, Rajan A, Lernmark A, Balasubramanyam A Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab 2003; 88: 5090-5098.
16. Valabhji J, Watson M, Cox J, Poulter C, Elwig C, Elkeles RS. Type 2 diabetes presenting as diabetic ketoacidosis in adolescence. Diabet Med 2003; 20: 416-417.
17. Hathout EH, Thomas W, El-Shahawy M, Nahab F, Mace JW. Diabetic autoimmune markers in children and adolescents with type 2 diabetes. Pediatrics 2001; 107: e102.
18. Kaufman FR. Type 2 diabetes in children and youth. Rev Endocr Metab Disord 2003; 4: 33-42.
19. Dabelea D, Pettitt DJ, Jones KL, Arslanian SA. Type 2 diabetes mellitus in minority children and adolescents. An emerging problem. Endocrinol Metab Clin North Am 1999; 28: 709-729, viii.
20. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999; 22: 345-354.
21. Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TP, Glaser NS, Hanas R, Hintz RL, Levitsky LL, Savage MO, Tasker RC, Wolfsdorf JI; ESPE; LWPES. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child 2004; 89: 188-194.
22. Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline JP, Kevorkian JP, Vaisse C, Charpentier G, Guillausseau PJ, Vexiau P, Gautier JF. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes 2004; 53: 645-653.
23. Mauvais-Jarvis F, Smith SB, Le May C, Leal SM, Gautier JF, Molokhia M, Riveline JP, Rajan AS, Kevorkian JP, Zhang S, Vexiau P, German MS, Vaisse C. PAX4 gene variations predispose to ketosis-prone diabetes. Hum Mol Genet 2004; 13: 3151-3159.
24. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002; 346: 802-810.
25. Sabbah E, Savola K, Ebeling T, Kuhnala P, Vahasalo P, Ilonen J, Sahnela PI, Knip M.. Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes. Diabetes Care 2000; 23: 1326-1332.
26. Komulainen J, Kuhnala P, Savola K, Lounamaa R. Ilonen J, Reijonen H, Knip M, Akerblom HK. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 1999; 22: 1950-1955.
27. Delaney MF, Zisman A, Kettyle WM. Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Endocrinol Metab Clin North Am 2000; 29: 683-705, V.
28. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 2003; 52: 1-8.
29. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003; 46: 3-19.
30. Burge MR, Garcia N, Qualls CR, Schade DS. Differential effects of fasting and dehydration in the pathogenesis of diabetic ketoacidosis. Metabolism 2001; 50: 171-177.
31. Goldstein BJ. Insulin resistance as the core defect in type 2 diabetes mellitus. Am J Cardiol 2002; 90: 3-10G.
32. Balasubramanyam A, Zern JW, Hyman DJ, Pavlik V. New profiles of diabetic ketoacidoiis: type 1 vs type 2 diabetes and the effect of ethnicity. Arch Intern Med 1999; 159: 2317-2322.
33. Banerji MA, Chaiken RL, Lebovitz HE. Long-term normoglycemic remission in Black newly diagnosed NIDDM subjects. Diabetes 1996; 45: 337-341.